R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Director - Global Forecasting

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA

About the Job

Requirements

  • A bachelor's degree is required; an MBA is preferred.
  • At least 12 years of progressive experience in pharmaceutical, biotechnology, or strategic consulting roles, including at least 8 years in a related forecasting role.
  • Experience developing long-range, patient-based oncology forecasts and complex scenarios that capture interactions among products and indications within a tumor type and across a portfolio.
  • Experience translating forecast uncertainty and portfolio scenarios into insights for long-range planning, supply planning, investment prioritization, and go/no-go decisions.
  • Experience developing and supporting early-stage forecasting efforts, with comfort navigating ambiguity, uncertainty, and rapidly evolving information and priorities.
  • Experience working with global, regional, and local teams to establish shared forecasting approaches, explain material differences, and provide practical analytical support tailored to local needs and capabilities.
  • Experience leveraging research and analytical vendors, selecting study designs, and building effective vendor partnerships.
  • Experience in a smaller, rapidly growing company.
  • Ability to influence senior management and key business partners.
  • Ability to prioritize effectively and deliver results within established timelines.
  • Strong verbal and written communication skills and interpersonal skills.

Responsibilities

  • Lead a team of forecasters responsible for developing and maintaining global forecast models for a tumor type and integrating forecasts to assess interactions across products, indications, and the broader portfolio.
  • Ensure alignment with global forecasting standards and governance processes; partner with global and regional forecasting leads to establish and maintain shared methodologies, core assumptions, scenario definitions, and forecast reviews, balancing consistency with justified market differences.
  • Develop and maintain patient-based forecasts and complex scenarios within indications and across the portfolio as products and indications enter the same tumor type; assess treatment sequencing, overlapping eligible populations, combinations, launch timing, substitution, and complementary use to quantify incremental portfolio opportunity and avoid double counting patients and demand.
  • Communicate key forecast assumptions to internal stakeholders and align them around those assumptions.
  • Understand complex markets, disease states, competitive landscapes, and relevant market and managed-care dynamics to develop strategic forecasts and plans.
  • Synthesize and communicate similarities, differences, and considerations that inform global clinical development plans.
  • Conduct opportunity assessments, sensitivity analyses, and risk quantification to clarify uncertainties, interdependencies, and decision thresholds for portfolio prioritization, investment, and go/no-go decisions; partner with the Portfolio Strategy team to develop processes and systems.
  • Partner with the forecasting team, Finance, Supply Chain, and cross-functional teams to translate patient, treatment-duration, and utilization assumptions into revenue and demand scenarios for long-range plans, budgets, supply and capacity planning, and launch readiness; communicate forecast ranges, risks, and changes to inform timely decisions.
  • Partner with Disease Area Insights, Data Analytics, and other Insights and Analytics functions to inform forecasts.
  • Work with Global Commercial Development, Clinical Development, Portfolio Strategy, Finance, and Medical Affairs to support early-stage decision-making.
  • Work with regional teams to maintain consistency and communicate forecast differences; document and reconcile material differences in assumptions, methods, and outputs with rationale reflecting local evidence and market conditions, and ensure implications are understood in global and regional planning.
  • Provide forecasting expertise, tools, and hands-on analytical support to regional and local teams, adapting support to local capabilities and priorities; help teams apply the shared framework, build capabilities, and share insights and effective practices across markets.
  • Maintain an in-depth understanding of the company's product offerings, competitive positioning, and broader market dynamics.
  • Collaborate with vendor partners to manage deliverables and analyses.
  • Travel domestically and internationally as needed, typically up to 25–30%.

Desired Qualifications

  • At least 8 years of experience in patient-based forecasting, with a focus on oncology.
  • Experience with targeted oncolytics.
  • Experience managing teams.
  • Ability to synthesize complex information and influence decision-making at the executive level.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs